Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
PREDNISOLONE
Le Vet Beheer B.V.
QH02AB06
PREDNISOLONE
5 Milligram
Tablets
POM
Canine, Feline
Prednisolone
Corticosteroid
Authorised
2015-10-23
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Prednicortone 5 mg tablets for dogs and cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 tablet contains ACTIVE SUBSTANCE: Prednisolone 5 mg EXCIPIENT(S): For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. Light brown with brown spots, round and convex flavoured tablet with a cross-shaped break line on one side. Tablets can be divided into 2 or 4 equal parts. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the symptomatic treatment or as adjunct treatment of inflammatory and immune-mediated diseases in dogs and cats. 4.3 CONTRAINDICATIONS Do not use in animals suffering from viral or mycotic infections. Do not use in animals suffering from diabetes mellitus or hyperadrenocorticism. Do not use in animals with osteoporosis. Do not use in animals suffering from cardiac or renal dysfunction. Do not use in animals suffering from corneal ulcers. Do not use in animals with gastro-intestinal ulceration. Do not use in animals with burns. Do not use concomitantly with live attenuated vaccines. Do not use in the case of glaucoma. Do not use during pregnancy (see section 4.7). Do not use in known cases of hypersensitivity to the active substance, to corticosteroids or to any of the excipients. See also section 4.8. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Corticoid administration is to induce an improvement in clinical signs rather than a cure. The treatment should be combined with treatment of the underlying disease and/or environmental control. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 08/12/2015_ _CRN Read the complete document